• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颗粒蛋白前体:理解和治疗神经退行性疾病的新途径。

Progranulin: a new avenue towards the understanding and treatment of neurodegenerative disease.

机构信息

Endocrine Research Laboratory, Royal Victoria Hospital, and McGill University Health Centre Research Institute, Centre for Translational Biology, Platform in Metabolic Disorders and Complications, 1001 Decarie Boulevard, QC, Canada, H4A 3J1.

出版信息

Brain. 2017 Dec 1;140(12):3081-3104. doi: 10.1093/brain/awx198.

DOI:10.1093/brain/awx198
PMID:29053785
Abstract

Progranulin, a secreted glycoprotein, is encoded in humans by the single GRN gene. Progranulin consists of seven and a half, tandemly repeated, non-identical copies of the 12 cysteine granulin motif. Many cellular processes and diseases are associated with this unique pleiotropic factor that include, but are not limited to, embryogenesis, tumorigenesis, inflammation, wound repair, neurodegeneration and lysosome function. Haploinsufficiency caused by autosomal dominant mutations within the GRN gene leads to frontotemporal lobar degeneration, a progressive neuronal atrophy that presents in patients as frontotemporal dementia. Frontotemporal dementia is an early onset form of dementia, distinct from Alzheimer's disease. The GRN-related form of frontotemporal lobar dementia is a proteinopathy characterized by the appearance of neuronal inclusions containing ubiquitinated and fragmented TDP-43 (encoded by TARDBP). The neurotrophic and neuro-immunomodulatory properties of progranulin have recently been reported but are still not well understood. Gene delivery of GRN in experimental models of Alzheimer's- and Parkinson's-like diseases inhibits phenotype progression. Here we review what is currently known concerning the molecular function and mechanism of action of progranulin in normal physiological and pathophysiological conditions in both in vitro and in vivo models. The potential therapeutic applications of progranulin in treating neurodegenerative diseases are highlighted.

摘要

颗粒蛋白前体(Progranulin)是一种分泌型糖蛋白,由人类单个 GRN 基因编码。颗粒蛋白前体由七个半串联重复的、非同源的 12 个半胱氨酸颗粒素基序组成。许多细胞过程和疾病都与这种独特的多功能因子有关,包括但不限于胚胎发生、肿瘤发生、炎症、伤口修复、神经退行性变和溶酶体功能。GRN 基因的常染色体显性突变导致的单倍不足会导致额颞叶痴呆,这是一种进行性神经元萎缩的疾病,在患者中表现为额颞叶痴呆。额颞叶痴呆是一种早发性痴呆,与阿尔茨海默病不同。GRN 相关的额颞叶痴呆是一种蛋白病,其特征是神经元内含物的出现,这些内含物含有泛素化和碎片化的 TDP-43(由 TARDBP 编码)。颗粒蛋白前体的神经营养和神经免疫调节特性最近被报道,但仍不被完全理解。在阿尔茨海默病和帕金森病样疾病的实验模型中,GRN 的基因传递抑制了表型的进展。在这里,我们回顾了目前已知的颗粒蛋白前体在体外和体内模型中正常生理和病理生理条件下的分子功能和作用机制。强调了颗粒蛋白前体在治疗神经退行性疾病方面的潜在治疗应用。

相似文献

1
Progranulin: a new avenue towards the understanding and treatment of neurodegenerative disease.颗粒蛋白前体:理解和治疗神经退行性疾病的新途径。
Brain. 2017 Dec 1;140(12):3081-3104. doi: 10.1093/brain/awx198.
2
A novel frameshift GRN mutation results in frontotemporal lobar degeneration with a distinct clinical phenotype in two siblings: case report and literature review.一种新型的移码GRN突变导致两兄弟出现具有独特临床表型的额颞叶痴呆:病例报告及文献综述
BMC Neurol. 2017 Sep 15;17(1):182. doi: 10.1186/s12883-017-0959-2.
3
Modifiers of GRN-Associated Frontotemporal Lobar Degeneration.GRN 相关额颞叶变性的修饰物。
Trends Mol Med. 2017 Oct;23(10):962-979. doi: 10.1016/j.molmed.2017.08.004. Epub 2017 Sep 7.
4
Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia.海藻糖可上调GRN单倍剂量不足的人类和小鼠模型中的颗粒蛋白前体表达:一种治疗额颞叶痴呆的新型治疗线索。
Mol Neurodegener. 2016 Jun 24;11(1):46. doi: 10.1186/s13024-016-0114-3.
5
Brain progranulin expression in GRN-associated frontotemporal lobar degeneration.脑颗粒蛋白前体在 GRN 相关额颞叶变性中的表达。
Acta Neuropathol. 2010 Jan;119(1):111-22. doi: 10.1007/s00401-009-0576-2. Epub 2009 Aug 2.
6
Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation.Tau 蛋白表达减少与颗粒蛋白基因突变所致额颞叶变性有关。
Acta Neuropathol Commun. 2016 Jul 19;4(1):74. doi: 10.1186/s40478-016-0345-0.
7
A morphometric study of the spatial patterns of TDP-43 immunoreactive neuronal inclusions in frontotemporal lobar degeneration (FTLD) with progranulin (GRN) mutation.TDP-43 免疫反应性神经元包含物在伴有颗粒蛋白前体(GRN)突变的额颞叶变性(FTLD)中的空间模式的形态计量研究。
Histol Histopathol. 2011 Feb;26(2):185-90. doi: 10.14670/HH-26.185.
8
Restoring neuronal progranulin reverses deficits in a mouse model of frontotemporal dementia.恢复神经元中的原肌球蛋白可逆转额颞叶痴呆小鼠模型中的缺陷。
Brain. 2017 May 1;140(5):1447-1465. doi: 10.1093/brain/awx060.
9
Cortical degeneration in frontotemporal lobar degeneration with TDP-43 proteinopathy caused by progranulin gene mutation.由原颗粒蛋白基因突变引起的伴TDP - 43蛋白病的额颞叶痴呆中的皮质变性。
Int J Neurosci. 2014 Dec;124(12):894-903. doi: 10.3109/00207454.2014.890620. Epub 2014 Mar 3.
10
Elevated TMEM106B levels exaggerate lipofuscin accumulation and lysosomal dysfunction in aged mice with progranulin deficiency.颗粒蛋白前体缺乏的老年小鼠 TMEM106B 水平升高可加剧脂褐素堆积和溶酶体功能障碍。
Acta Neuropathol Commun. 2017 Jan 26;5(1):9. doi: 10.1186/s40478-017-0412-1.

引用本文的文献

1
Development of AL101 (GSK4527226), a progranulin-elevating monoclonal antibody, as a potential treatment for Alzheimer's disease.AL101(GSK4527226),一种能提高原纤维蛋白水平的单克隆抗体,作为阿尔茨海默病潜在治疗方法的研发。
Alzheimers Res Ther. 2025 Jul 25;17(1):174. doi: 10.1186/s13195-025-01817-4.
2
LATE-NC Stage 3: a diagnostic rubric to differentiate severe LATE-NC from FTLD-TDP.晚期神经认知障碍3期:一种区分重度晚期神经认知障碍与额颞叶痴呆-4型的诊断标准。
Acta Neuropathol. 2025 Apr 28;149(1):38. doi: 10.1007/s00401-025-02876-5.
3
Progranulin deficiency in the brain: the interplay between neuronal and non-neuronal cells.
大脑中的颗粒蛋白前体缺乏:神经元与非神经元细胞之间的相互作用
Transl Neurodegener. 2025 Apr 16;14(1):18. doi: 10.1186/s40035-025-00475-8.
4
Levels of DEFA1, Progranulin, and NRG4 in Patients with Autonomic Neuropathy: Potential Biomarkers for Diagnosis and Prognosis.自主神经病变患者中防御素1、颗粒蛋白前体和神经调节蛋白4的水平:诊断和预后的潜在生物标志物
Metabolites. 2025 Mar 2;15(3):169. doi: 10.3390/metabo15030169.
5
Regulatory Mechanisms and Therapeutic Implications of Lysosomal Dysfunction in Alzheimer's Disease.阿尔茨海默病中溶酶体功能障碍的调节机制及治疗意义
Int J Biol Sci. 2025 Jan 13;21(3):1014-1031. doi: 10.7150/ijbs.103028. eCollection 2025.
6
Influence of CReatine Supplementation on mUScle Mass and Strength After Stroke (ICaRUS Stroke Trial): A Randomized Controlled Trial.补充肌酸对卒中后肌肉质量和力量的影响(ICaRUS卒中试验):一项随机对照试验。
Nutrients. 2024 Nov 29;16(23):4148. doi: 10.3390/nu16234148.
7
Nicorandil treatment improves survival and spatial learning in aged granulin knockout mice.尼可地尔治疗可提高老年颗粒蛋白敲除小鼠的生存率和空间学习能力。
Brain Pathol. 2025 May;35(3):e13312. doi: 10.1111/bpa.13312. Epub 2024 Oct 22.
8
Intrinsic link between PGRN and Gba1 D409V mutation dosage in potentiating Gaucher disease.PGRN 与 Gba1 D409V 突变剂量之间的内在联系增强了戈谢病。
Hum Mol Genet. 2024 Oct 7;33(20):1771-1788. doi: 10.1093/hmg/ddae113.
9
Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results.颗粒蛋白前体 AAV 基因治疗额颞叶痴呆:转化研究和 1/2 期试验中期结果。
Nat Med. 2024 May;30(5):1406-1415. doi: 10.1038/s41591-024-02973-0. Epub 2024 May 14.
10
A systematic review of progranulin concentrations in biofluids in over 7,000 people-assessing the pathogenicity of GRN mutations and other influencing factors.一项针对超过 7000 人的生物流体中颗粒蛋白前体浓度的系统评价——评估 GRN 突变的致病性和其他影响因素。
Alzheimers Res Ther. 2024 Mar 28;16(1):66. doi: 10.1186/s13195-024-01420-z.